玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

Karenitecin

    
≥98%

Karenitecin

源葉(MedMol)
S89555 一鍵復制產品信息
203923-89-1
C25H28N2O4Si
448.58632
MFCD09833216
(4S)-4-乙基-4-羥基-11-(2-三甲基硅基)乙基)-1H-吡喃并[3',4':6,7]氮茚并[1,2-B]喹啉-3,14(4H,12H)-二酮;BNP 1350; Cositecan; UNII-24R60NVC41;
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S89555-5mg
≥98% ¥5500.00 貨期:3-5天 - - -
S89555-10mg
≥98% ¥8500.00 貨期:3-5天 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.

產品描述: Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.
靶點: Topoisomerase I;Topoisomerase
體外研究: Karenitecin is a topoisomerase I inhibitor, with potent anti-cancer activity. Karenitecin inhibits cell growth of A253 cells with IC10, IC50, and IC90 values of 0.01, 0.07, and 0.7 μM after 2 h treatment. Karenitecin induces DNA damage (0.01, 0.07, and 0.7 μM), and increases cyclin E and cdk2 protein expression in A253 cells (0.07, and 0.7 μM). Karenitecin markedly enhances the cyclin B/cdc2-associated kinase activity at low concentration, but slightly suppresses this kinase activity at higher concentration. Karenitecin inhibits several human colon cancer cell lines such as COLO205, COLO320, LS174T, SW1398 and WiDr cells, with IC50s of 2.4 nM, 1.5 nM, 1.6 nM, 2.9 nM, and 3.2 nM, respectively
體內研究: Karenitecin shows maximum growth inhibition of 61% on COLO320 cells and 54% on COLO205 colon cancer cells via i.p. administration of 1 mg/kg in mice. Karenitecin (1.0 mg/kg daily × 5 i.p.) significantly suppresses growth inhibition both in the parental Pgp-negative xenografts and in the Pgp-positive xenografts
參考文獻: 1. Yin MB, et al. Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350. Mol Pharmacol. 2000 Mar;57(3):453-9. 2. Van Hattum AH, et al. New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. Int J Cancer. 2000 Oct 15;88(2):260-6.
溶解性: Soluble  in  DMSO
保存條件: 2-8℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.229 ml 11.146 ml 22.292 ml
5 mM 0.446 ml 2.229 ml 4.458 ml
10 mM 0.223 ml 1.115 ml 2.229 ml
50 mM 0.045 ml 0.223 ml 0.446 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 叙永县| 华阴市| 仙居县| 河东区| 晋州市| 武乡县| 开江县| 进贤县| 揭西县| 滦南县| 东乌| 泗阳县| 凌云县| 苏尼特右旗| 益阳市| 德令哈市| 澄城县| 来凤县| 沅江市| 寿阳县| 盐源县| 临高县| 吕梁市| 图木舒克市| 汉源县| 保定市| 永安市| 来安县| 永清县| 侯马市| 松桃| 黄平县| 澎湖县| 阿图什市| 甘孜县| 郑州市| 桐梓县| 防城港市| 亚东县| 特克斯县| 平武县|